Scientific progress over the past four decades in the response to the HIV/Aids pandemic has been nothing short of extraordinary. Combination antiretroviral therapy has transformed the disease form a death sentence to a chronically manageable disease.
Some 26 million people around world are now on lifesaving antiretroviral treatment, two-thirds of them from the African continent. Yet each year some 1.5 million people are newly infected with the virus and another 10 million are still failing to access treatment. The cost of maintaining so many people on treatment, at $50 billion going forwards, is also unsustainable in the long term
